Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

Synthetic biology company AbSci ’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Source Type: news